Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jun-ichi Ueyama"'
Autor:
Keisuke Okuno, Naohiro Yoneda, Rei Nishimura, Hitoshi Sano, Jun-ichi Ueyama, Hiroaki Komatsu, Tasuku Harada, Michiko Matsushita, Satoshi Kuwamoto, Yasushi Horie, Susumu Kanzaki
Publikováno v:
Yonago Acta Medica; 2019, Vol. 62 Issue 3, p263-267, 5p
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 59(10)
Autor:
Ryoji, Kobayashi, Shosuke, Sunami, Tetsuo, Mitsui, Atsuko, Nakazawa, Yuhki, Koga, Takeshi, Mori, Fumiko, Tanaka, Jun-ichi, Ueyama, Tomoo, Osumi, Reiji, Fukano, Kentaro, Ohki, Masahiro, Sekimizu, Tetsuya, Mori
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 57(4)
Results of pediatric lymphoma treatment have improved markedly over the past 30 years. In Hodgkin's lymphoma, the 5 year event-free survival (EFS) was 81.5% in a retrospective study. In the ALB-NHL03 study, the 5 year EFS according to clinical stage
Autor:
H. Nakajima, A. Yokota, Yuji Tanaka, T. Sakura, Shin Ichiro Mori, Hisashi Sakamaki, Kishi K, Nahoko Hatsumi, Jun-ichi Ueyama, S. Miyawaki, Shin Fujisawa, Masayuki Oki, Shigesaburo Miyakoshi
Publikováno v:
Clinical & Laboratory Haematology. 25:383-391
Summary We conducted a multi-center phase I/II trial of nonmyeloablative stem cell transplantation for patients with hematologic malignancies. The aim of this trial was to assess the safety and feasibility of this treatment modality for older or youn
Autor:
Eiji Kusumi, Yoshitomo Mutou, Yoshinobu Kanda, Yoichi Takaue, Masahiro Kami, Shin ichi Momomura, Shin Mineishi, Jun Ichi Ueyama, Shinichi Morinaga, Tamae Hamaki, Shigesaburo Miyakoshi
Publikováno v:
American Journal of Hematology. 71:196-199
A 54-year-old man with chronic myelocytic leukemia in blastic phase received reduced-intensity transplantation (RIST) from an HLA-identical unrelated donor. The preparative regimen consisted of busulfan, fludarabine, and anti-thymocyte globulin. Graf
Autor:
Yukiko Kishi, Tomoko Matsumura, Shigesaburo Miyakoshi, Jun-Ichi Ueyama, Shinichi Morinaga, Masaya Mori, Masaki Miyazaki, Hirokoinagawa, Masahiro Kami, Yoshitomo Muto, Hiroshi Matsushita, Utako Machida, Shohei Kawagoe
Publikováno v:
Leukemia & Lymphoma. 40:441-444
Fusarium infection is rare but important infection after bone marrow transplantation (BMT). A 27-year-old man developed systemic fusarial infection following severe skin damage probably caused by high-dose thiotepa administration. Systemic fusariosis
Autor:
Takuya, Hanada, Keisuke, Okuno, Shin-ichi, Okada, Masanobu, Fujimoto, Hiroki, Kuranobu, Yuichiro, Hashida, Jun-ichi, Ueyama, Jun, Murakami, Atsushi, Hayashi, Keiichi, Hanaki, Susumu, Kanzaki
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 54(5)
We report a 14-year-old boy with Castleman disease in this article. He complained of short stature, and his body height was 133.8 cm (3rd percentile; z score -4.5). There was marked delay in the appearance of secondary sexual characteristics. He was
Autor:
Jun-Ichi, Ueyama, Akira, Kure, Keisuke, Okuno, Hitoshi, Sano, Naohiro, Tamoto, Susumu, Kanzaki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 53(4)
Translocation (8;21)/AML1-ETO is considered a favorable cytogenetic abnormality in acute myeloid leukemia (AML). However, the outcomes associated with KIT mutations in AML1-ETO have not been elucidated. A 16-year-old boy was diagnosed with recurrent
Autor:
Masahiro Kami, Shinichi Morinaga, Mieko Kogi, Yukiko Kishi, Jun Ichi Ueyama, Yasuhiro Oki, Yoshinobu Kanda, Yoshitomo Muto, Utako Machida
Publikováno v:
Transplantation. 71:581-583
Autor:
Yukiko, Kishi, Masahiro, Kami, Eiji, Kusumi, Tomoka, Mineyama, Daisuke, Kato, Tamae, Hamaki, Jun-ichi, Ueyama, Shigesaburo, Miyakoshi, Shin-ichi, Morinaga, Yoshitomo, Muto, Shuichi, Taniguchi
Publikováno v:
Haematologica. 89(5)
Intravascular large B-cell lymphoma (IVL) has been treated as fever of unknown origin (FUO), and many patients have been treated inadequately based on incorrect diagnoses. We previously cares for a patient with IVL who tested positive for prostatic a